NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE11870 Query DataSets for GSE11870
Status Public on Jul 23, 2008
Title Gene expression changes in primary aortic endothelial cells during expression of dominant negative PPAR gamma (V290M).
Organism Mus musculus
Experiment type Expression profiling by array
Summary Ligand-mediated activation of the nuclear hormone receptor PPAR gamma lowers blood pressure and improves glucose tolerance in humans. Two naturally occurring mutations (P467L, V290M) in the ligand binding domain of PPAR gamma have been described in humans that lead to severe insulin resistance and hypertension. Experimental evidence suggests that these mutant versions of PPAR gamma act in a dominant negative fashion. To better understand the molecular mechanisms underlying PPAR gamma action in the vasculature, we determined the global gene expression profile in primary aortic endothelial cells in response to endothelial cell specific expression of a dominant negative isoform of PPAR gamma (V290M).
 
Overall design We generated transgenic mice specifically targeting expression of dominant negative human PPAR gamma to the endothelium using an endothelial-specific promoter (vascular endothelial cadherin or CDH5). Primary aortic endothelial cells were isolated from 10 non-transgenic and 10 EC-DN mice by Dominion Pharmakine (http://www.pharmakine.com/). For each group, 5 cultures of cells were established. Each culture was derived from 2 mice and remained separate from the other cultures. Cellular RNA was prepared using conventional methods and quality was assessed using the Bioanalyzer 2100 (Agilent Technologies). For the microarray hybridizations, RNA from 3 of the cultures in each group was used. All the microarray procedures were conducted at the University of Iowa DNA Core facility using standard Affymetrix protocols. In brief, approximately 50 ng of total RNA was used as input to a two-step amplification procedure (NuGen, http://www.nugeninc.com/) to generate biotin-labeled RNA fragments for hybridization to the Affymetrix GeneChip Mouse Genome 430 2.0 array.
 
Contributor(s) Keen HL, Sigmund CD, Beyer AM, Halabi CM, de Lange WJ, Faraci FM
Citation(s) 18676352, 25675995
Submission date Jun 24, 2008
Last update date Feb 11, 2019
Contact name Henry Keen
E-mail(s) henry-keen@uiowa.edu
Phone 319-335-8926
Organization name University of Iowa
Department Pharmacology
Lab Dr. Curt D. Sigmund's Laboratory
Street address 2-370 BSB
City Iowa City
State/province IA
ZIP/Postal code 52242
Country USA
 
Platforms (1)
GPL1261 [Mouse430_2] Affymetrix Mouse Genome 430 2.0 Array
Samples (6)
GSM299778 Primary aortic endothelial cells, Non_transgenic_control_1
GSM299779 Primary aortic endothelial cells, Non_transgenic_control_2
GSM299780 Primary aortic endothelial cells, Non_transgenic_control_3
Relations
BioProject PRJNA105681

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE11870_RAW.tar 24.6 Mb (http)(custom) TAR (of CEL)
Processed data included within Sample table

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap